Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics

Acute Respiratory Tract Infections Clinical Trial

Official title:

Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00989482
• Other study ID #: Fulbright-Gonzales
• Status: Completed
• Phase: N/A
• First received: July 24, 2009
• Last updated: May 12, 2011
• Start date: January 2010
• Est. completion date: September 2010

Study information

• Verified date: May 2011
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Health authority: Mexico: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to improve antibiotic prescribing practices of Mexican primary care physicians for patients seeking care for acute respiratory tract infections (ARIs). The investigators will employ a combination of qualitative and quantitative methods to develop and evaluate a patient education and physician decision-support intervention.

Hypothesis 1: The investigators will identify barriers and facilitators of appropriate antibiotic use for ARIs that can be addressed through patient education and physician decision-support.

Hypothesis 2: The proportion of patients who report desire for antibiotics as a "very important" reason for seeking care will decrease from 50% to 30% following exposure to the educational intervention; and 90% (95% confidence interval: 80% to 100%) of patients will report that they trust the information provided by the computer.

Hypothesis 3: Antibiotic prescribing for adults with uncomplicated acute bronchitis will decrease from 80 percent to 40 percent following the introduction of a real-time clinical decision support tool.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 847
• Est. completion date: September 2010
• Est. primary completion date: June 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• adults age 18 years or greater

Exclusion Criteria:

• mental disability; severe illness

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Acute Respiratory Tract Infections
• Respiratory Tract Infections

Intervention

Behavioral:
• Computer kiosk Education
computerized patient education; guidelines for physicians

Locations

Country	Name	City	State
Mexico	IMSS Family Practice Clinic #1	Cuernavaca	Morelos

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Francisco

Country where clinical trial is conducted

Mexico, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	antibiotic prescription rate		4 months	No